Overview


According to FutureWise analysis the market for hemodialysis in 2023 is US$ 94.36 billion, and is expected to reach US$ 139.63 billion by 2031 at a CAGR of 5.02%.

Haemodialysis is a procedure to filter water and waste from an individual’s blood. Haemodialysis helps regulate vital blood minerals like potassium, salt, and calcium as well as blood pressure. The process is vital for kidney transplant and end-stage renal disease (ESRD) treatment. When an individual undergoes treatment of haemodialysis, blood passes through a dialyzer (external filter) which is sometimes also referred as ‘’artificial kidney”.

Throughout each dialysis session, a patient's blood is continually circulated through the dialyser. Dialysis sessions typically last four hours and occur three times a week. Longer sessions are necessary for larger individuals and for those who tend to accumulate more fluid between dialysis treatments. For those who are underweight, have kidneys that are still partially functioning, or receive treatment more than three times per week, shorter sessions may be used. Haemodialysis can be administered in a hospital, at home, or in satellite units that are freestanding dialysis units. While nurses and dialysis aides assist patients receiving treatment in hospitals and satellite facilities, home dialysis requires an individual or someone else to learn how to operate the machine. Patients may experience fatigue following a dialysis session, but since haemodialysis is only performed up to three times per week, the days in between can often still be spent engaging in regular activities with some limitations on diet and fluid intake.

FutureWise Market Research has published a report that provides an insightful analysis of haemodialysis market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the haemodialysis market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • FRESENIUS
  • NIKKISO
  • DIVERUM (Gambro)
  • ASAHI KASEI
  • NIPRO  
  • B. BRAUN
  • NXSTAGE
  • TORAY
  • BELLCO
  • ALLMED

Recent developments by key players in Haemodialysis Market:

  • In November 2022, Fresenius Medical Care North America's (FMCNA) Renal Therapies Group announced that they have received FDA’s approval for AquaA™ water system, which is water purification system available for haemodialysis.

Covid-19 pandemic outbreak had a major impact on the population receiving haemodialysis. Up to 25% of critically ill SARS-CoV-2 patients were reported to have acute kidney injury (AKI), particularly those who had underlying comorbidities. In this situation, AKI was linked to significant mortality rates, due to which renal replacement therapy became necessary. Due to individuals being affected by pandemic globally, there will be an increased need for dialysis services, which is anticipated to boost the revenue growth prospects of haemodialysis market. Also, increasing incidence of individuals receiving haemodialysis developing sepsis (blood poisoning) which caused patients to opt for alternative treatments, which is said to hamper the target market’s growth. However, technological advancements and the introduction of advanced tools such as enhanced purifying dialyzers, and the use of nanotechnology to create novel membranes are some factors anticipated to propel the growth of haemodialysis market in the years to come.

By Type

  • Conventional (3 times per week)
  • Daily (6 days a week)
  • Nocturnal (3-6 nights per week)

 By Product & Services

  • Equipment
  • Consumable
  • Drug
  • Service

By End User

  • In-centre dialysis
  • Home dialysis

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Europe registered highest share in the market in 2022. The rising rates of diabetes and cardiovascular disease are primarily responsible for the increase in renal failure cases. According to studies, chronic kidney disease (CKD), which currently affects 100 million people in Europe, is predicted to overtake heart disease as the fifth leading cause of death by 2040. CKD also ranks among the most expensive medical conditions, with estimated yearly costs of 140 billion Euros in Europe. In the upcoming years, the market expansion is also projected to be fuelled by shifting eating patterns and an unhealthy lifestyle.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Haemodialysis Market by type, by product and services, by end-user, by region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Hemodialysis Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hemodialysis Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Hemodialysis Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Hemodialysis Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Conventional (3 times per week)
        2. Daily (6 days a week)
        3. Nocturnal (3-6 nights per week)

  • 8.   Hemodialysis Market, By Product & Services Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Equipment
        2. Consumable
        3. Drug
        4. Service

  • 9.   Hemodialysis Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. In-center dialysis
        2. Home dialysis

  • 10.   North America Hemodialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Hemodialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Hemodialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Hemodialysis Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. FRESENIUS
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. NIKKISO.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. DIVERUM (Gambro)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ASAHI KASEI
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. NIPRO
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B.BRAUM
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. NXSTAGE
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. TORAY
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. BELLCO
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. ALLMED
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients